Dr. Khalid bin Jabr Al Thani speaking during the meeting.
Doha, Qatar: Qatar Cancer Society (QCS) held its Ordinary General Assembly Meeting for the year ending 2025, chaired by Dr. Khalid bin Jabr Al Thani, Chairman of the Board, and attended by members of the General Assembly and the Board of Directors, under the supervision of the Regulatory Authority for Charitable Activities.
The meeting reviewed the Society’s institutional and programmatic achievements in 2025, highlighting their tangible impact in supporting patients, raising community awareness, advancing professional development, and promoting scientific research.
It also underscored efforts to strengthen national and international partnerships, reinforcing the Society’s position as a key national pillar in Qatar’s cancer control ecosystem.
The General Assembly discussed the agenda items, which included the Board of Directors’ annual report for 2025, the annual achievements report aligned with the strategic plan, approval of the final financial statements, discharge of the Board from liability for 2025, approval of the proposed budget for 2026, review of the external auditor’s report, appointment of an auditor, and the election of Board members for the 2026–2029 term.
In accordance with the Society’s bylaws, the Chair of the meeting announced that the candidates for Board membership for the 2026–2029 term were elected by acclamation, without the need for a secret ballot, following completion of all required procedures.
The General Assembly approved the results, and the Board members for the new term were announced Dr. Khalid bin Jabr Al Thani as Chairman, Dr. Abdulazim Abdulwahab Hussein as Vice Chairman, Dr. Khalid Abdullah Al Ali as Board Member, Mohammed Juma Al Kuwari as Board Member, and Mohammed Issa Al Fadala as Board Member.
The Society affirmed that 2025 marked a significant milestone in its journey, as it continued to translate its vision into tangible achievements through a comprehensive package of initiatives and services targeting patients, survivors, and the wider community.
Founded in 1997 as a charitable organisation operating under the supervision of the Regulatory Authority for Charitable Activities, the Qatar Cancer Society is a key national pillar in Qatar’s cancer control system.
The Society is guided by a clear vision of “a cancer-aware community and a better life for those affected,” and a humanitarian mission that relies on donations and community partnerships to provide awareness services, as well as financial, psychological, and social support for patients, survivors, and their families, in addition to contributing to professional development and scientific research in the field of cancer.
In 2025, the Society continued its humanitarian role in supporting patients unable to afford treatment through its digital platform “Wayyakom,” covering the treatment of approximately 1,750 adult and paediatric patients at an estimated cost of QR49m. Additionally, 1,200 individuals directly benefited from psychological and social support programmes, while indirect beneficiaries exceeded 40,000, alongside specialised individual psychological support services provided to 50 survivors.
In the field of community awareness—considered the first line of defence against cancer—the Society continued to implement specialised campaigns and programs through its Cancer Awareness Centre, the first of its kind in the Middle East. In 2025, more than 6,659,500 indirect beneficiaries were reached, in addition to 18,950 direct beneficiaries through workshops, programs, and field awareness activities.
The Society also sustained its efforts in professional development and scientific research, with a total of 16,248 beneficiaries from these programmes, underscoring its role in supporting national competencies and strengthening research and development in cancer.
At the partnership and institutional levels, the Society recorded several notable accomplishments in 2025, including membership in Qatar’s National Cancer Control Framework, the Gulf Federation for Cancer Control, and the Union for International Cancer Control (UICC).
It also won the Qatar CSR Award 2025 and secured the rights to host the global Relay for Life event. Furthermore, the Society established 17 strategic partnerships with governmental and private entities and implemented more than 80 awareness initiatives in collaboration with schools, universities, and various institutions.
At the conclusion of the General Assembly meeting, the Society reaffirmed its commitment to strengthening governance, transparency, and sustainability principles, while continuing to develop its services, programmes, and initiatives to enhance the quality of life of patients, survivors, and their families, and to reinforce its role as a leading national organisation in cancer control in Qatar.
